Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma

Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma

BackgroundMelphalan is the most common conditioning regimen used prior to autologous stem cell transplant (ASCT); however, there are varying data on optimal melphalan timing prior to transplant for best safety and efficacy. Historically, ASCT conditioning consisted of melphalan 200 mg/m2 on day 2 (D...

Full description

Bibliographic Details
Main Authors: Aimee Merino, Ryan Shanley, Faridullah Rashid, Jenna Langer, Michelle Dolan, Sarah Tu, Najla El Jurdi, John Rogosheske, Kirollos Hanna, Todd DeFor, Murali Janakiram, Daniel Weisdorf
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
melphalan
autologous stem cell transplant
myeloma
engraftment
rehospitalization
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1310752/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1310752/full

Similar Items